The clinical response to infliximab in rheumatoid arthritis is in part dependent on pre-treatment TNFα expression in the synovium

نویسندگان

  • Carla A. Wijbrandts
  • Marcel G. W. Dijkgraaf
  • Maarten C. Kraan
  • Marjolein Vinkenoog
  • Tom. J. Smeets
  • Huib Dinant
  • Koen Vos
  • Willem F. Lems
  • Gerrit Jan Wolbink
  • Dorine Sijpkens
  • Ben A. C. Dijkmans
  • Paul P. Tak
  • Jan van Breemen
چکیده

1 Division of Clinical Immunology and Rheumatology, and 2 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center/ University of Amsterdam, Amsterdam, the Netherlands. 3 Jan van Breemen Institute, Amsterdam, The Netherlands. 4 Department of Rheumatology, Slotervaart Hospital, Amsterdam, The Netherlands. VU Medical Center, Amsterdam, The Netherlands. * Present address Schering Plough Research Institute.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium

OBJECTIVE To determine whether the heterogeneous clinical response to tumour necrosis factor (TNF)alpha blocking therapy in rheumatoid arthritis (RA) can be predicted by TNFalpha expression in the synovium before initiation of treatment. METHODS Prior to initiation of infliximab treatment, arthroscopic synovial tissue biopsies were obtained from 143 patients with active RA. At week 16, clinic...

متن کامل

Pre-Treatment Whole Blood Gene Expression Is Associated with 14-Week Response Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging in Infliximab-Treated Rheumatoid Arthritis Patients

UNLABELLED Approximately 30% of rheumatoid arthritis patients achieve inadequate response to anti-TNF biologics. Attempts to identify molecular biomarkers predicting response have met with mixed success. This may be attributable, in part, to the variable and subjective disease assessment endpoints with large placebo effects typically used to classify patient response. Sixty-one patients with ac...

متن کامل

Infliximab treatment for rheumatic disease: clinical and radiological efficacy

Infliximab is a chimeric anti-tumour necrosis factor α (TNFα) monoclonal antibody with high affinity and binding specificity for human TNFα. Results from several well designed, controlled clinical trials show repeated infusions of infliximab with concomitant methotrexate (MTX) treatment can reduce the signs and symptoms of rheumatoid arthritis (RA). This combination of infliximab and MTX also s...

متن کامل

TNFα Promotes Th17 Cell Differentiation through IL-6 and IL-1β Produced by Monocytes in Rheumatoid Arthritis

TNFα plays an important role in autoimmune pathogenesis and is the main therapeutic target of rheumatoid arthritis. However, its underlying mechanism is not completely understood. In this study, we described that Th17 cells were accumulated in synovial fluid, which was attributable to TNFα aberrantly produced in rheumatoid synovium. Interestingly, TNFα cannot induce IL-17 production of CD4(+) T...

متن کامل

Effectiveness of Acceptance- and Commitment-Based Therapy on Pain Perception and Functional Disability in Women with Rheumatoid Arthritis

Background and Aim: Rheumatoid arthritis is the most common and most important type of arthritis caused by interaction of genetic, immunologic, psychological and social factors and is accompanied by chronic pains. The aim of this study was to investigate the effectiveness of treatment based on acceptance and commitment to the perception of pain and functional disability of women with rheumatoid...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007